Related Experiment Video
Updated: Jul 2, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Watchful waiting versus active surveillance: appropriate patient selection
Marc A Dall'Era1, Christopher J Kane
1Division of Urology, University of California, San Diego, UCSD Medical Center, 200 West Arbor Drive #8897, San Diego, CA 92103, USA.
Active surveillance offers a viable approach for managing low-risk prostate cancer, balancing treatment side effects with cancer progression monitoring. This strategy defers immediate intervention for carefully selected patients, prioritizing quality of life.
Area of Science:
- Oncology
- Urology
- Cancer Screening and Management
Background:
- Prostate-specific antigen (PSA) screening has altered prostate cancer diagnosis, leading to earlier detection of lower-stage disease.
- Many low-grade, low-stage prostate cancers exhibit slow growth and minimal risk of metastasis or mortality.
- Patient concerns regarding treatment-related sexual and urinary dysfunction are significant factors in treatment decisions.
Purpose of the Study:
- To review the concept and application of active surveillance in prostate cancer management.
- To differentiate active surveillance from watchful waiting and establish inclusion criteria.
- To compare follow-up protocols, indications for intervention, and outcomes following active surveillance.
Main Methods:
- Review of existing literature on active surveillance for prostate cancer.
- Comparison of active surveillance with watchful waiting protocols.
- Analysis of inclusion criteria, follow-up regimens, and intervention outcomes.
Main Results:
- Active surveillance is presented as an attractive alternative to immediate treatment for select prostate cancer patients.
- The review defines criteria for patient selection and outlines various follow-up strategies.
- Outcomes and indications for intervention post-active surveillance are discussed.
Conclusions:
- Active surveillance provides a framework for managing low-risk prostate cancer while mitigating treatment side effects.
- Further support is advocated for prospective clinical trials comparing active surveillance with immediate definitive treatment.
- This approach aims to optimize patient quality of life alongside oncological outcomes.
Related Concept Videos
Naturalistic Observations
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Bioavailability Study Design: Healthy Subjects Versus Patients
Principles of Disease Surveillance
Comparing the Survival Analysis of Two or More Groups
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
